Neupharmsp. z o.o.
Other professional, scientific and technical activities, not elsewhere classified
Overview
Neupharm is an owner-managed, GMP-certified pharmaceutical manufacturer and wholesaler operating since 2014 across 38 regulated markets. It offers 34 injectable products with full EU documentation and distributes pharmaceuticals, cosmetics and supplements.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 977 days for 2021).
- 2025not filed
- 202402/09/2025
- 202318/03/2025
- 202203/09/2024
- 202118/03/2025
- 202024/01/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Offer
- Pharmaceutical products
- Dietary supplements
- Dermatological cosmetics
- Pharmaceutical sourcing
- Medicine distribution
- Regulatory documentation services
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Akman Pharma İlaç Sanayi̇ Ve Diş Ti̇caret Li̇mi̇ted Şi̇rketi̇ | 4,000 | $54,024.85 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-11-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nobipharmsp. z o.o. | $9,447,565.32 | nobipharm.pol.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-03 | Share capital increase (5,000.00 PLN → 200,000.00 PLN) | |
| 2025-04-03 | PKD change (Removed: 3 codes; Added: 4 codes) | |
| 2024-07-31 | Address change (Ul. Chełmska 30/34, 00-725, Warszawa → Ul. Ługowa 85, 96-320, Mszczonów) | |
| 2022-04-06 | Address change (Ul. Rybnicka 21, 02-405, Warszawa → Ul. Chełmska 30/34, 00-725, Warszawa) | |
| 2020-07-09 | Address change (Ul. Mieszczańska 6a, 20-311, Lublin → Ul. Rybnicka 21, 02-405, Warszawa) |
FAQ
Last updated: 2026-10-07